Pricing Log in Create free account
Friday 6 November 2026 Export TGTX’s income statement to Excel — free account

TG Therapeutics, Inc.

TGTX Healthcare Biotechnology

TG Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $616.3 million, up 87.3% from fiscal 2024.

Revenue
+70.3%
EPS
−73.7%
Free cash flow
+427.1%
Total debt
+204.2%

Quarter to June 2026, against a year earlier

59.37 1.39 +2.40%
Market cap
$8.9B
P/E
19.1×
Fwd P/E
62.4×
Dividend yield
—
F-score
5/9
Altman Z
6.29
Beneish M
0.80
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

TG Therapeutics, Inc. (TGTX) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, TG Therapeutics, Inc. (TGTX) trades at a P/B ratio of 13.6×. Over the past ten years it has ranged from 0.0× (June 2020) to 179× (May 2023); the current reading is higher than 67% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 6.6× (66.25%)
FY2024 19.7× 30.52%
FY2023 15.1× (43.64%)
FY2022 26.7× 152.44%
FY2021 10.6× (8.30%)
FY2020 11.6× (54.52%)
FY2019 25.4× 97.33%
FY2018 12.9× 58.79%
FY2017 8.1× 33.24%
FY2016 6.1× 13.49%

Quarterly newest first

Period P/B ratio Change
Jun 2026 12.9× 56.70%
Mar 2026 8.2× 23.94%
Dec 2025 6.6× (23.27%)
Sep 2025 8.7× (54.71%)
42 more quarters

Against its own ten years

Low 0.0× High 179×
Ten-year median 10.2×
Current reading's percentile 62

P/B ratio against peers

Company P/B ratio
CYTK Cytokinetics, Incorporated compare n/m
IBRX ImmunityBio, Inc. compare n/m
KRYS Krystal Biotech, Inc. compare 6.2×
SYRE Spyre Therapeutics, Inc. compare 9.5×
PTGX Protagonist Therapeutics, Inc. compare 10.6×
CAI Caris Life Sciences,�Inc. compare 12.7×
TGTX TG Therapeutics, Inc. 13.6×
TWST Twist Bioscience Corporation compare 17.1×
MDGL Madrigal Pharmaceuticals, Inc. compare 18.7×
Biotechnology industry median 2.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on TGTX